Analysis of leukocyte membrane protein interactions using protein microarrays.
BACKGROUND
Protein microarrays represent an emerging class of proteomic tools to investigate multiple protein-protein interactions in parallel. A sufficient proportion of immobilized proteins must maintain an active conformation and an orientation that allows for the sensitive and specific detection of antibody and ligand binding. In order to establish protein array technology for the characterization of the weak interactions between leukocyte membrane proteins, we selected the human leukocyte membrane protein CD200 (OX2) and its cell surface receptor (hCD200R) as a model system. As antibody-antigen reactions are generally of higher affinity than receptor-ligand binding, we first analyzed the reactivity of monoclonal antibodies (mAb) to normal and mutant forms of immobilized CD200R.


RESULTS
Fluorescently labelled mAb DX147, DX136 and OX108 were specifically reactive with immobilized recombinant hCD200R extracellular region, over a range of 0.1-40 microg ml(-1) corresponding to a limit of sensitivity of 0.01-0.05 femtomol per spot. Orientating hCD200R using capture antibodies, showed that DX147 reacts with an epitope spatially distinct from the more closely related DX136 and OX108 epitopes. A panel of soluble recombinant proteins with mutations in hCD200R domain 1 produced by transiently transfected cells, was arrayed directly without purification and screened for binding to the three mAb. Several showed decreased binding to the blocking mAb DX136 and OX108, suggesting close proximity of these epitopes to the CD200 binding site. Binding of hCD200 to directly immobilized rat, mouse, and hCD200R was achieved with multimeric ligands, in the form of biotinylated-hCD200 coupled to FITC-labelled avidin coated beads.


CONCLUSIONS
We have achieved sensitive, specific and reproducible detection of immobilized CD200R with different antibodies and mapped antigenic epitopes for two mAb in the vicinity of the ligand binding site using protein microarrays. We also detected CD200 binding to its receptor, a low affinity interaction, using beads presenting multivalent ligands. Our results demonstrate the quantitative aspects of protein arrays and their potential use in detecting simultaneously multiple protein-protein interactions and in particular the weak interactions found between leukocyte membrane proteins.
Letarte
Michelle
M
Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. mablab@sickkids.ca <mablab@sickkids.ca>
Voulgaraki
Despina
D
Hatherley
Deborah
D
Foster-Cuevas
Mildred
M
Saunders
Nigel J
NJ
Barclay
A Neil
AN
D000818:Animals; D006801:Humans; D007962:Leukocytes / Q000378:metabolism*; D008565:Membrane Proteins / Q000737:chemistry* / Q000378:metabolism*; D051379:Mice; D040081:Protein Array Analysis / Q000379:methods*; D011485:Protein Binding / Q000502:physiology; D025941:Protein Interaction Mapping; D017433:Protein Structure, Secondary / Q000502:physiology; D051381:Rats
D008565:Membrane Proteins
Nature. 1999 Dec 16;402(6763):715-20
10617183
Nat Genet. 1999 Jan;21(1 Suppl):48-50
9915501
Immunity. 2000 Aug;13(2):233-42
10981966
Science. 2000 Dec 1;290(5497):1768-71
11099416
Genome Biol. 2001;2(2):RESEARCH0004
11182887
Immunology. 2001 Feb;102(2):173-9
11260322
Clin Chem Lab Med. 2001 Mar;39(3):209-14
11350016
Biotechniques. 2001 Jul;31(1):186-90, 192-4
11464511
Cancer Res. 2001 Oct 15;61(20):7585-93
11606398
Clin Immunol. 2001 Dec;101(3):328-34
11726225
Trends Biotechnol. 2002 Apr;20(4):160-6
11906748
Trends Immunol. 2002 Jun;23(6):285-90
12072366
Clin Immunol. 2002 Sep;104(3):256-64
12217336
Anal Biochem. 2003 Jan 15;312(2):113-24
12531195
Curr Opin Chem Biol. 2003 Feb;7(1):55-63
12547427
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5366-71
12697893
Cancer Cell. 2003 Apr;3(4):317-25
12726858
Immunity. 2003 Aug;19(2):213-23
12932355
J Immunol. 2003 Sep 15;171(6):3034-46
12960329
Eur J Immunol. 2004 Jun;34(6):1688-94
15162439
J Virol. 2004 Jul;78(14):7667-76
15220441
J Biol Chem. 1990 Jun 25;265(18):10410-8
2113054
Immunity. 1999 Feb;10(2):219-25
10072074
Biochim Biophys Acta. 1999 Mar 25;1423(2):M17-28
10214349
Cell. 1999 Jun 11;97(6):791-803
10380930
J Pharm Biomed Anal. 1989;7(2):155-68
2488616
Ann Biol Clin (Paris). 1990;48(9):655-66
2099119
Nature. 1992 Nov 19;360(6401):232-9
1279440
Protein Eng. 1994 Apr;7(4):515-21
7518084
Trends Biochem Sci. 1994 Sep;19(9):354-8
7985226
J Biol Chem. 1995 Jan 6;270(1):369-75
7529232
Curr Opin Immunol. 1996 Apr;8(2):257-61
8725949
Nat Genet. 1996 Dec;14(4):457-60
8944026
J Protein Chem. 1997 Jul;16(5):537-44
9246641
Eur J Immunol. 1997 Aug;27(8):1911-8
9295026
J Exp Med. 1998 Dec 7;188(11):2083-90
9841922
Science. 2000 Sep 8;289(5485):1760-3
10976071